These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29966778)

  • 61. Differential gene expression of sirtuins between somatotropinomas and nonfunctioning pituitary adenomas.
    Grande IPP; Amorim PVGH; Freire ACTB; Jallad RS; Musolino NR; Cescato VA; da Silva GO; Bronstein MD; Trarbach EB
    Pituitary; 2018 Aug; 21(4):355-361. PubMed ID: 29564694
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Differential expression of galectin-3 in pituitary tumors.
    Riss D; Jin L; Qian X; Bayliss J; Scheithauer BW; Young WF; Vidal S; Kovacs K; Raz A; Lloyd RV
    Cancer Res; 2003 May; 63(9):2251-5. PubMed ID: 12727847
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunohistochemical expression of Insulin-like growth factor-1, Transforming growth factor-beta1, and Vascular endothelial growth factor in parathyroid adenoma and hyperplasia.
    Sayar H; Sahin M; Dogan PO; Karabulut S; Seringec N; Oguz A
    Indian J Pathol Microbiol; 2014; 57(4):549-52. PubMed ID: 25308005
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Expression of pituitary tumor transforming gene, endostatin, and basic fibroblast growth factor mRNAs in invasive pituitary adenomas].
    Chen L; Liu YS; Wang LS; Yin HG; Hou QT; Liu ZX; Chen LH; Ling F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):651-3, 666. PubMed ID: 16114549
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Proteomic Profiles Associated With Postsurgical Progression in Nonfunctioning Pituitary Adenomas.
    Hallén T; Johannsson G; Thorsell A; Olsson DS; Örndal C; Engvall A; Jacobson F; Widgren A; Bergquist J; Skoglund T
    J Clin Endocrinol Metab; 2024 May; 109(6):1485-1493. PubMed ID: 38157275
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Relations of transforming growth factor-beta1 expression to differentiation and prognosis of advanced gastric cancer].
    Guo RF; Zang SZ; Zhang L; Li WM; Hu FL; Lü YY
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3249-54. PubMed ID: 17313802
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Expression of pituitary homeo box 1 (Ptx1) in human non-neoplastic pituitaries and pituitary adenomas.
    Tahara S; Kurotani R; Sanno N; Takumi I; Yoshimura S; Osamura RY; Teramoto A
    Mod Pathol; 2000 Oct; 13(10):1097-108. PubMed ID: 11048804
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Accurate assessment of estrogen receptor profiles in non-functioning pituitary adenomas using RT-digital PCR and immunohistochemistry.
    Hattori Y; Ishii H; Tahara S; Morita A; Ozawa H
    Life Sci; 2020 Nov; 260():118416. PubMed ID: 32926922
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Transforming growth factor-β1 gene promoter -509C/T polymorphism in association with expression affects colorectal cancer development and depends on gender.
    Stanilova S; Stanilov N; Julianov A; Manolova I; Miteva L
    PLoS One; 2018; 13(8):e0201775. PubMed ID: 30071009
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Survivin products in pituitary tumors.
    Jankowska A; Wasko R; Waligorska-Stachura J; Andrusiewicz M; Jaskula M; Liebert W; Sowinski J
    Neuro Endocrinol Lett; 2008 Dec; 29(6):1033-7. PubMed ID: 19112393
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Typical and atypical pituitary adenomas: a single-center analysis of outcome and prognosis.
    Chiloiro S; Doglietto F; Trapasso B; Iacovazzo D; Giampietro A; Di Nardo F; de Waure C; Lauriola L; Mangiola A; Anile C; Maira G; De Marinis L; Bianchi A
    Neuroendocrinology; 2015; 101(2):143-50. PubMed ID: 25633744
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Prohibitin suppresses renal interstitial fibroblasts proliferation and phenotypic change induced by transforming growth factor-beta1].
    Guo W; Xu H; Huang WY; Chen J; Yang Y; Fu R; Liu HM; Zha XL; Zhang ZG
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1660-5. PubMed ID: 17825142
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Growth hormone receptor expression and function in pituitary adenomas.
    Clausen LR; Kristiansen MT; Rasmussen LM; Billestrup N; Blaabjerg O; Ledet T; Jørgensen JO
    Clin Endocrinol (Oxf); 2004 May; 60(5):576-83. PubMed ID: 15104560
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Minichromosome maintenance protein 7 as prognostic marker of tumor aggressiveness in pituitary adenoma patients.
    Coli A; Asa SL; Fadda G; Scannone D; Chiloiro S; De Marinis L; Lauretti L; Ranelletti FO; Lauriola L
    Eur J Endocrinol; 2016 Mar; 174(3):307-14. PubMed ID: 26620390
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Decreased TAp63 and ΔNp63 mRNA Levels in Most Human Pituitary Adenomas Are Correlated with Notch3/Jagged1 Relative Expression.
    Mezzomo LC; Pesce FG; Marçal JM; Haag T; Ferreira NP; Lima JF; Leães CG; Oliveira MC; da Fonte Kohek MB
    Endocr Pathol; 2017 Mar; 28(1):13-21. PubMed ID: 28078618
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
    Xu W; Wang LW; Shi JZ; Gong ZJ
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy.
    Zhang Q; Helfand BT; Jang TL; Zhu LJ; Chen L; Yang XJ; Kozlowski J; Smith N; Kundu SD; Yang G; Raji AA; Javonovic B; Pins M; Lindholm P; Guo Y; Catalona WJ; Lee C
    Clin Cancer Res; 2009 May; 15(10):3557-67. PubMed ID: 19447876
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Urocortin expression in human pituitary gland and pituitary adenoma.
    Iino K; Sasano H; Oki Y; Andoh N; Shin RW; Kitamoto T; Totsune K; Takahashi K; Suzuki H; Nagura H; Yoshimi T
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3842-50. PubMed ID: 9360550
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Metalloproteinases ADAM12 and MMP-14 are associated with cavernous sinus invasion in pituitary adenomas.
    Wang J; Voellger B; Benzel J; Schlomann U; Nimsky C; Bartsch JW; Carl B
    Int J Cancer; 2016 Sep; 139(6):1327-39. PubMed ID: 27144841
    [TBL] [Abstract][Full Text] [Related]  

  • 80. WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer.
    Wissmann C; Wild PJ; Kaiser S; Roepcke S; Stoehr R; Woenckhaus M; Kristiansen G; Hsieh JC; Hofstaedter F; Hartmann A; Knuechel R; Rosenthal A; Pilarsky C
    J Pathol; 2003 Oct; 201(2):204-12. PubMed ID: 14517837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.